Home | Structured Search | Drug Resource
Find: within
Mammalian Bites > Consultation for Management Author: Jeffrey D. Kravetz, MD; Daniel G. Federman, MD
Editorial changes - 2008-01-23
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Human hand bites, especially clenched fist injuries, carry a high risk of joint and bone involvement and need to be debrided by a surgical subspecialist.
  • Improper care of human hand bite infections increases morbidity and is associated with a higher risk of amputation.
  • Dog bites from large dogs can cause fractures of bone, as they can exert up to 450 psi of force.
  • Children are susceptible to facial bite wounds from dog bites and thus are more likely to develop facial fractures.
  • Facial wounds often can be closed primarily, and a plastic surgeon can improve the cosmetic outcome.

Evidence:

  • Inadequate initial surgical management of human hand bite wounds was partially responsible for amputation in 18 of 100 patients seen in an emergency department for human hand bites (23).
  • Twenty-three of 24 patients admitted with osteomyelitis of the hand from human bite wounds did not have adequate surgical debridement of the wound within 24 hours of the bite (29).
  • A review of all U.S. emergency department visits for dog bites over a 3-year period revealed that 73% of bites in children ages 0 to 9 involved the head, face, and neck, whereas only 30% involved the head, face, and neck in all other ages (70).
  • Though the exact incidence of facial fractures occurring with dog bite injuries is unknown, it is estimated to occur in 5% or less of facial dog bite wounds (71).

Comments:

  • None.

FAQs
Daniel G. Federman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Jeffrey D. Kravetz, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.